beta-amyrenone

ID: ALA461060

Cas Number: 638-97-1

PubChem CID: 12306160

Max Phase: Preclinical

Molecular Formula: C30H48O

Molecular Weight: 424.71

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Synonyms: Beta-Amyrenone | Beta-Amyrinone | beta-Amyrone|beta-amyrenone|638-97-1|Beta-Amyrinone|beta-Amyron|CHEMBL461060|(4aR,6aR,6bS,8aR,12aR,14aR,14bR)-4,4,6a,6b,8a,11,11,14b-octamethyl-2,4a,5,6,7,8,9,10,12,12a,14,14a-dodecahydro-1H-picen-3-one|EX-A6671|HY-N2925|BDBM50242248|AKOS040761409|AC-37065|CS-0023532

Canonical SMILES:  CC1(C)CC[C@]2(C)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CCC(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1

Standard InChI:  InChI=1S/C30H48O/c1-25(2)15-16-27(5)17-18-29(7)20(21(27)19-25)9-10-23-28(6)13-12-24(31)26(3,4)22(28)11-14-30(23,29)8/h9,21-23H,10-19H2,1-8H3/t21-,22-,23+,27+,28-,29+,30+/m0/s1

Standard InChI Key:  LIIFBMGUDSHTOU-CFYIDONUSA-N

Molfile:  

     RDKit          2D

 34 38  0  0  0  0  0  0  0  0999 V2000
    3.1713  -25.3995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1713  -26.2268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8852  -26.6362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8852  -24.9816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5992  -25.3995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6003  -26.2268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3133  -26.6372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0299  -26.2248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3112  -24.9826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0245  -25.3999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0324  -23.7501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3120  -24.1585    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7457  -24.1674    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7350  -24.9896    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4380  -25.4076    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1560  -25.0079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4591  -23.7630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1633  -24.1866    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8783  -23.7906    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8951  -22.9696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1909  -22.5462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4698  -22.9437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6002  -21.9565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5988  -21.8271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1559  -23.3563    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4554  -26.6414    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.4539  -24.5888    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    3.1629  -27.0456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0946  -27.4342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5960  -27.0498    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    5.3064  -25.8089    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    6.7269  -25.8131    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0166  -24.5722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5919  -24.5722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 14 15  1  0
 15 16  1  0
 16 18  1  0
 17 18  1  0
  6  7  1  0
  7  8  1  0
  8 10  1  0
  9 10  1  0
  3  6  1  0
  5  4  1  0
 17 22  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
  5  6  1  0
 21 23  1  0
 21 24  1  0
  9 12  1  0
 18 25  1  1
 10 14  1  0
  2 26  2  0
 13 11  2  0
 17 27  1  1
 11 12  1  0
  3 28  1  0
 13 14  1  0
  3 29  1  0
  1  2  1  0
  6 30  1  6
  1  4  1  0
  9 31  1  6
  2  3  1  0
 14 32  1  6
  5  9  1  0
 10 33  1  1
 13 17  1  0
  5 34  1  1
M  END

Alternative Forms

  1. Parent:

    ALA461060

    beta-Amyrone

Associated Targets(Human)

ALOX5 Tclin Arachidonate 5-lipoxygenase (6568 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALOX15B Tchem Arachidonate 15-lipoxygenase, type II (7244 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CES2 Tchem Carboxylesterase 2 (583 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CES1 Tchem Acyl coenzyme A:cholesterol acyltransferase (1029 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Nos2 Nitric oxide synthase, inducible (3573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Akr1b1 Aldose reductase (4007 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
B16 (5829 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS1 Cyclooxygenase-1 (5266 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 424.71Molecular Weight (Monoisotopic): 424.3705AlogP: 8.38#Rotatable Bonds:
Polar Surface Area: 17.07Molecular Species: NEUTRALHBA: 1HBD:
#RO5 Violations: 1HBA (Lipinski): 1HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 7.97CX LogD: 7.97
Aromatic Rings: Heavy Atoms: 31QED Weighted: 0.36Np Likeness Score: 3.29

References

1. Morikawa T, Kishi A, Pongpiriyadacha Y, Matsuda H, Yoshikawa M..  (2003)  Structures of new friedelane-type triterpenes and eudesmane-type sesquiterpene and aldose reductase inhibitors from Salacia chinensis.,  66  (9): [PMID:14510595] [10.1021/np0301543]
2. Hata K, Hori K, Takahashi S..  (2002)  Differentiation- and apoptosis-inducing activities by pentacyclic triterpenes on a mouse melanoma cell line.,  65  (5): [PMID:12027734] [10.1021/np0104673]
3. Tsao CC, Shen YC, Su CR, Li CY, Liou MJ, Dung NX, Wu TS..  (2008)  New diterpenoids and the bioactivity of Erythrophleum fordii.,  16  (22): [PMID:18926710] [10.1016/j.bmc.2008.09.021]
4. Rashad AA, Mahalingam S, Keller PA..  (2014)  Chikungunya virus: emerging targets and new opportunities for medicinal chemistry.,  57  (4): [PMID:24079775] [10.1021/jm400460d]
5. Vo NNQ, Nomura Y, Muranaka T, Fukushima EO..  (2019)  Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.,  82  (12): [PMID:31774676] [10.1021/acs.jnatprod.9b00538]
6. Zhang JF,Zhong WC,Li YC,Song YQ,Xia GY,Tian GH,Ge GB,Lin S.  (2020)  Bioactivity-Guided Discovery of Human Carboxylesterase Inhibitors from the Roots of Paeonia lactiflora.,  83  (10): [PMID:32951423] [10.1021/acs.jnatprod.0c00464]

Source